Business Standard
Monday, Nov 23, 2009
 
drived banner
drived banner
  Advanced Search
Feedback | RSS
Content Guide
Follow us on  
  Home  ||||||||| 
 BS Headlines | News Now | BS Weekend | The strategist | The Smart Investor | Lunch with BS | Columnists | BS 1000
Home Live Markets | Smart Portfolios II
  Search:
     Search Results   wyeth
 
Wyeth profit declines 25%; appoints Kewal Handa as MD26-OCT-09
Drug maker Wyeth reported 25 per cent decline in its net profit at Rs 25.19 crore for the second quarter ended September 30, over the corresponding period a year earlier.
Wyeth becomes part of Pfizer17-OCT-09
Drug maker Wyeth today said it has become part of Pfizer Inc, following the merger of its parent company — Wyeth — with the global pharma major.
Domestic drug maker Wyeth becomes part of Pfizer16-OCT-09
Drug maker Wyeth today said it has become part of Pfizer Inc, following the merger of its parent company -- Wyeth -- with the global pharma major.
US court rules in favour of Orchid, rejects restraining order25-SEP-09
Drug firm, Orchid Chemicals & Pharmaceuticals today said a US court has rejected Wyeth's request for a temporary restraining order (TRO) to prevent the Indian company from launching the generic version of the antibiotic injections, Piperacillin and Tazobactam in the US.
Gates foundation exits pharma cos to enter energy16-AUG-09
The Bill & Melinda Gates Foundation, created by the billionaire founder of Microsoft Corp, sold almost all its pharmaceutical holdings, including Wyeth, Merck & Co and Eli Lilly & Co, and bought shares of energy companies.
Wyeth June qtr net up 10% at Rs 29 cr17-JUL-09
Pharma major Wyeth today said its net profit rose by 9.79 per cent to Rs 29.15 crore for the quarter ended June 30, 2009 over the same period last year.
Lupin settles antidepressant drug litigation with Wyeth12-MAY-09
Lupin, a generic drug maker, has settled all patent litigation with US drug maker Wyeth for Effexor XR capsules, the US firm’s branded anti-depressant.
Lupin reaches settlement with Wyeth on Venlafaxine11-MAY-09
Lupin has settled all ongoing with Wyeth relating to Venlafaxine extended release capsules.
Glenmark, Piramal Life Sciences, SMS Pharma & Wyeth Q3 results28-JAN-09
Glenmark Pharmaceuticals consolidated net profit in the December quarter declined 70.91 per cent to Rs 81.43 crore, compared to Rs 280 crore in the December quarter last year. Consolidated net revenue also declined to Rs 581.38 crore in the third quarter of the current financial year from Rs 679.39 crore a year ago.
Pfizer-Wyeth may climb to No 2 spot28-JAN-09
The merger of Pfizer and Wyeth is expected to create the second-biggest drug maker among multinational companies in India. The world's largest drug maker Pfizer yesterday announced a $68-billion acquisition of US-based Wyeth.
Wyeth Q3 net up 19% at Rs 21 cr27-JAN-09
Pharmaceutical firm Wyeth today said its net profit in the December quarter grew 18.52 per cent at Rs 20.79 crore over the corresponding year-ago period.
Indian arms of Pfizer, Wyeth to merge soon27-JAN-09
The decision of Pfizer to acquire rival drugmaker Wyeth in a $68-billion cash-and-stock deal will also see merger of the listed Indian subsidiaries of both US multinationals soon.
Pfizer's $68 billion Wyeth deal eases Lipitor loss27-JAN-09
Pfizer Inc, the world’s biggest drugmaker, will buy Wyeth for about $68 billion after failing to reduce its dependence on the cholesterol pill Lipitor with new drugs from its own research labs.
Pfizer to acquire Wyeth for $68 bn26-JAN-09
Pharmaceutical major Pfizer today said it will buy out rival firm Wyeth for $68 billion in a cash-and-stock transaction.
Pfizer, Wyeth close to deal: reports26-JAN-09
Drugmakers Pfizer and Wyeth are closing in on a deal worth $68 billion that could be announced before the markets open today, according to published reports.
Go to page:   1    2    3    4    Next  [  ]    
  
Most Popular
Read
E-Mailed
Commented
   
- IAF orders more Tejas LCAs to replace MiG-21s
- Suzlon shifts global HQ ops back to India
- Indian CIOs more progressive than global counterparts: IBM study
- Tata docomo extends per second billing to roaming
- India denied access to 11 of 16 US dual use technology regimes
 
 More  
BS Poll
Cast Your Vote
 
   
 
Should sugar prices be decontrolled?
  Yes  No
Submit

  Hot Searches  
 
Amitabh Bachchan | N Chandrasekaran | Swine Flu | Mukesh Ambani | Anil Ambani | TCS | Infosys |  Air India |  Duronto |  Pranab Mukherjee | Sonia Gandhi | Congress | Rahul Gandhi |  Bigg Boss |  New Pension Scheme |  Service tax |  Excise duty |  Sebi | Tech Mahindra |  Ramalinga Raju |  Satyam |  Reliance  |  RBI |  GDP |  Gold |  Ratan Tata |  ICICI |  |  B-School | DLF  Sensex |  Tax calculator | Home Loan  | Bollywood | Personal Finance |  inflation | oil prices |  World Bank | Reliance Infratel |  HDFC |  Barack Obama  
  Member Area Write to the Editor RSS Archives Advanced Search
  Subscribe to BS print product BS e-paper Newsletter Portfolio Tracker
  BS Products BS Hindi BS Motoring
FOR HOT PRODUCTS
BS Bazaar.com
Home | Markets & Investing | Companies & Industry | Banking & Finance | Economy & Policy | Opinion
Life & Leisure | Management & Marketing | Tech World
About Us | Partner With Us | Code of Conduct | Careers | Advertise with us| Terms & Conditions | Disclaimer | Site Map | Contact Us | Feedback